1. Search results in the navigational tree (All hits)
All the results are highlighted by color in the navigational tree
(at the left-hand side) and remain so until you click on a not highlighted menu item and
thus return to the usual content navigation.
In addition, you can browse through the search results consecutively by pressing the navigational buttons
(
<
1 of
28
>).
Within the text the search result is highlighted by color.
2. Search results by relevance (Top 5)
Following is a list of the 5 most important hits ranked by relevance.
Hint: In the
Help you will find explanations about using search operators in order to conduct an extended search.
The compensation of the Executive Board of Merck KGaA is paid by the general partner, E. Merck KG, and recorded as an expense in its income statement. For the period from January to December 2013 fixed salaries of € 4.9 million (2012: € 4.9 million), variable compensation of € 17.6 million (2012: € 11.2 million), and additional benefits of € 0.1 million (2012: € 0.1 million) were recorded for members of the Executive Board of Merck KGaA. Furthermore, additions to the provisions of E. Merck KG for the Long-Term Incentive Plan totaled € 8.0 million (2012: € 3.1 million), and to the pension provisions of E. Merck KG include current service costs of € [...]
Contrary to management board members of German stock corporations, the members of the Executive Board of Merck KGaA are not employed officers of the company. Rather, they are personally liable general partners of both Merck KGaA and the general partner E. Merck KG, and in this capacity they receive profit-based compensation from E. Merck KG. Given this context, the stipulations of the German Corporate Governance Code concerning the compensation of management board members of publicly listed German stock corporations as well as the individual disclosure thereof do not apply to the Executive Board members of Merck KGaA. Nevertheless, Merck KGaA has decided to [...]
(Click on the images below to view a brief biography of each Board member) Matthias Zachert Member of the Executive Board Chief Financial Officer Born in 1967, university degree in business administration; Joined Merck in June 2011 as a Member of the Executive Board Responsibility for Group functions: Group Accounting & Subsidiaries; Group Controlling & Risk Management; Corporate Finance; Group Tax; Group Procurement; Group Insurance; Investor Relations Stefan Oschmann Member of the Executive Board CEO Pharmaceuticals Born in 1957, veterinarian; Joined Merck in January 2011 as a Member of the Executive Board Responsibility for Group functions: Patents & [...]
Notes on memberships of statutory supervisory boards and comparable German and foreign supervisory bodies (section 285 No. 10 HGB in conjunction with section 125 (1) sentence 5 AktG). XLS Memberships of Member (a) (b) statutory supervisory boards and comparable German and foreign supervisory bodies of corporations 1 Matthias Zachert will leave the Executive Board of Merck KGaA as of March 31, 2014. Karl-Ludwig Kley Darmstadt, Chairman (a) – Bertelsmann SE & Co. KGaA, Gütersloh – Bertelsmann Management SE, Gütersloh – BMW AG, Munich (Vice Chairman) – Deutsche Lufthansa AG, Cologne (since May 7, 2013) – 1. FC Köln GmbH & Co KGaA, Cologne [...]
As of December 31, 2013, the members of the Executive Board and of the Supervisory Board either directly or indirectly held 13,692 shares of Merck KGaA. Their total ownership represents less than 1% of the issued shares of Merck KGaA. Transactions executed by members of the Executive Board and of the Supervisory Board are disclosed on the Merck website at Directors’ Dealings.
